BTIG lowers Xtant Medical buy rating to $1.5, maintains buy.

Tuesday, Nov 11, 2025 11:46 am ET1min read
XTNT--

BTIG lowers Xtant Medical buy rating to $1.5, maintains buy.

BTIG lowers Xtant Medical buy rating to $1.5, maintains buy.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet